Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway

Area of Science:

• Public Health
• Parasitology
• Tropical Medicine

Background:

• Ivermectin is being explored as a supplementary tool for vector control.
• Effective implementation requires robust evidence regarding its use in diverse eco-epidemiological settings.

Purpose of the Study:

• To review potential scenarios for mass drug administration (MDA) with ivermectin.
• To compare pharmacological strategies and guide the design of clinical trials.
• To suggest optimal timing and outcome measures for ivermectin-based vector control interventions.

Main Methods:

• Literature review of eco-epidemiological contexts for ivermectin MDA.
• Comparative analysis of potential scenarios and pharmacological approaches.
• Identification of suitable trial designs and outcome measures.

Main Results:

• Identified various eco-epidemiological settings where ivermectin MDA could be beneficial.
• Compared different strategies for ivermectin administration and timing.
• Proposed relevant outcome measures for evaluating ivermectin's efficacy in vector control.

Conclusions:

• Further high-quality evidence is essential for developing ivermectin as a complementary vector control tool.
• Strategic trial design, considering specific contexts and outcomes, is crucial for validating ivermectin's role.